Wells Fargo & Company Pfizer Inc Call Options Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $726,012 - $839,979	-20,100 Reduced 82.38%	4,300 $157,000
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $791,739 - $1.03 Million	20,100 Added 467.44%	24,400 $995,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $179,525 - $234,350	4,300 New	4,300 $220,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $17.4 Million - $21.5 Million	380,000 Added 1900.0%	400,000 $20.7 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $5.8 Million - $6.55 Million	-173,300 Reduced 89.65%	20,000 $725,000

Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $4.97 Million - $6.32 Million	-148,500 Reduced 43.45%	193,300 $104,000
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $3.22 Million - $3.78 Million	101,400 Added 42.18%	341,800 $243,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $7.24 Million - $8.78 Million	240,400 New	240,400 $17,000

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.